Ratna Prasad, Ph.D.

Affiliations: 
2005 Medical University of South Carolina, Charleston, SC, United States 
Area:
Molecular Biology, Pathology, Cell Biology, Immunology
Google:
"Ratna Prasad"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Inderjit Singh grad student 2005 MUSC
 (Modulation of monocyte-endothelial cell interaction by lovastatin, AICAR and GSNO: Implications for experimental autoimmune encephalomyelitis and multiple sclerosis.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Singh I, Prasad R, Agarwal V, et al. (2015) Does Rigid Cystoscopy Affect the Total Serum Prostate-Specific Antigen Levels? The Indian Journal of Surgery. 77: 365-9
Singh I, Prasad R. (2013) Primary urachal mucinous adenocarcinoma of the urinary bladder. Journal of Clinical and Diagnostic Research : Jcdr. 7: 911-3
Prasad R, Giri S, Singh AK, et al. (2008) 15-deoxy-delta12,14-prostaglandin J2 attenuates endothelial-monocyte interaction: implication for inflammatory diseases. Journal of Inflammation (London, England). 5: 14
Prasad R, Giri S, Nath N, et al. (2007) GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions. Glia. 55: 65-77
Nath N, Prasad R, Giri S, et al. (2006) T-bet is essential for the progression of experimental autoimmune encephalomyelitis. Immunology. 118: 384-91
Prasad R, Giri S, Nath N, et al. (2006) 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction. Journal of Neuroscience Research. 84: 614-25
Nath N, Giri S, Prasad R, et al. (2005) 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 175: 566-74
Prasad R, Giri S, Nath N, et al. (2005) Inhibition of phosphoinositide 3 kinase-Akt (protein kinase B)-nuclear factor-kappa B pathway by lovastatin limits endothelial-monocyte cell interaction. Journal of Neurochemistry. 94: 204-14
Nath N, Giri S, Prasad R, et al. (2004) Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy. Journal of Immunology (Baltimore, Md. : 1950). 172: 1273-86
See more...